We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Jayex Technology Limited is a health information services business based in Australia. Jayex Healthcare shares (JHL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Jayex Healthcare has a trailing 12-month revenue of around $6.6 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
| 52-week range | $0.025 - $0.067 |
|---|---|
| 50-day moving average | $0.0356 |
| 200-day moving average | $0.0424 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.008 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.034
| 1 month (2021-07-06) | 25.93% |
|---|---|
| 3 months (2021-05-06) | -5.56% |
Valuing Jayex Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Jayex Healthcare 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Jayex Healthcare 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $109,000 (£57,939).
The EBITDA is a measure of a Jayex Healthcare 's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $6.6 million |
|---|---|
| Gross profit TTM | $1.7 million |
| Return on assets TTM | -4.41% |
| Return on equity TTM | -21.2% |
| Profit margin | -12.09% |
| Book value | 0.017 |
| Market capitalisation | $6.4 million |
TTM: trailing 12 months
We're not expecting Jayex Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Jayex Healthcare 's shares have ranged in value from as little as $0.025 up to $0.067. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Jayex Healthcare 's is 1.3042. This would suggest that Jayex Healthcare 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Jayex Healthcare Limited develops healthcare industry service technologies and integrated dispensing automation systems for the pharmaceutical and healthcare sectors in Australia and the United Kingdom. The company offers Jayex Connect platform, a cloud-based patient engagement platform, which allow users for appointment booking, patient calling, patient check-in, health messaging, and script management. Jayex Healthcare Limited was founded in 2006 and is based in Milton, Australia.
Everything we know about the WAY2VAT IPO, plus information on how to buy in.
Everything we know about the Pearl Gull Iron IPO, plus information on how to buy in.
Everything we know about the Zoom2u Technologies IPO, plus information on how to buy in.
Copper Search is expected to go public . Here's how to buy in when the IPO launches.
Everything we know about the Alvo Minerals IPO, plus information on how to buy in.
Everything we know about the Star Minerals Limited IPO, plus information on how to buy in.
Everything we know about the Heavy Mineral Limited IPO, plus information on how to buy in.
Everything we know about the X2M Connect IPO, plus information on how to buy in.
Steps to owning and managing Industrial Minerals shares.
Everything we know about the SSH Group IPO, plus information on how to buy in.
